US Broker Ratings

AMN Healthcare Services Inc (AMN): Stock Analysis Reveals 30% Upside Potential Amidst Operational Challenges

Investors seeking opportunities in the healthcare sector might find AMN Healthcare Services Inc (NYSE: AMN) an intriguing prospect. Despite recent operational challenges, the company is showing signs of potential recovery,..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A 65% Potential Upside in the Promising Biotech Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is capturing investor attention with a promising upside potential of 65.17%, according to recent analyst ratings. Operating in the dynamic biotechnology sector, this clinical-stage company..

SI-BONE, Inc. (SIBN) Stock Analysis: A 47% Upside Potential in the Healthcare Sector

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector, is drawing significant attention from investors due to its innovative approach to addressing musculoskeletal disorders. With a focus on..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 23.59% Potential Upside in the Healthcare Sector

Investors with a keen eye on the medical devices industry should not overlook iRadimed Corporation (NASDAQ: IRMD). This healthcare sector player, headquartered in Winter Springs, Florida, is gaining traction with..

Iovance Biotherapeutics (IOVA) Stock Analysis: Exploring a Potential 357% Upside in the Biotech Sector

Investors with an appetite for high-risk, high-reward opportunities might find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. This biotechnology company, valued at approximately $781.41 million, operates within the healthcare..

Pharvaris N.V. (PHVS): Analyst Consensus Signals a 43.64% Upside for This Biotech Stock

Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology company, prominently stands out in the healthcare sector with its focus on developing innovative treatments for rare diseases. With a market cap of..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring a Potential 215% Upside in Gene Editing

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the healthcare sector, particularly within the dynamic field of biotechnology. With a market capitalization of $1.23 billion, this Cambridge, Massachusetts-based..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Powerhouse with 219% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical stage biotechnology company, is making waves in the healthcare sector with its innovative therapies targeting inflammatory bowel diseases (IBD) such as ulcerative colitis..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: 25% Upside Potential Amidst Healthcare Sector Expansion

Investors seeking exposure to the healthcare sector, particularly in the diagnostics and research industry, may find Fulgent Genetics, Inc. (NASDAQ: FLGT) an intriguing opportunity. With a market capitalization of approximately..

CareDx, Inc. (CDNA) Investor Outlook: Unpacking a 147.97% Potential Upside

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing significant attention from investors with its substantial potential upside of 147.97%. As..

Trevi Therapeutics, Inc. (TRVI) Investor Outlook: 210% Potential Upside Sparks Interest

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing attention in the biotech sector with its significant potential upside, as highlighted by recent analyst ratings. Based in New Haven, Connecticut, Trevi Therapeutics..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 27.59% Potential Upside for Investors

HealthStream, Inc. (NASDAQ: HSTM) is capturing the attention of investors with its promising potential upside of 27.59%, according to the latest analyst consensus. As a key player in the healthcare..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unpacking a Potential 225% Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) is a compelling case for investors with a keen eye on the biotechnology sector. Despite facing significant revenue challenges, the company presents an intriguing potential..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Evaluating a Promising 28.72% Potential Upside

In the ever-evolving world of biotechnology, LENZ Therapeutics, Inc. (NASDAQ: LENZ) stands out as a compelling story for investors. With a market capitalization of $973.01 million, this Solana Beach, California-based..

Beta Bionics, Inc. (BBNX) Stock Analysis: Unlocking a 78.93% Potential Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, is capturing investor attention with a significant potential upside of 78.93%. The company’s pioneering work in the medical..

uniQure N.V. (QURE) Stock Analysis: Unveiling a 136.80% Upside Potential in Gene Therapy Innovations

Investors interested in the biotechnology sector are increasingly turning their attention to uniQure N.V. (NASDAQ: QURE), a trailblazer in the development of gene therapies for rare diseases. With a market..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 32% Revenue Growth Amidst Valuation Concerns

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, specializes in manufacturing and marketing animal health products, mineral nutrition, and performance products across the globe. With..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring a Potential 137% Upside in the Biotech Space

Ardelyx, Inc. (NASDAQ: ARDX) is carving a niche in the biotechnology sector with its innovative therapies aimed at addressing unmet medical needs, and its financial metrics suggest a compelling opportunity..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 27.87% Potential Upside in Pain Management Innovation

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a dynamic player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, has been catching the eye of investors seeking potential..

InMode Ltd. (INMD) Stock Analysis: Uncovering a 20% Potential Upside in the Medical Devices Sector

In the dynamic world of medical devices, InMode Ltd. (NASDAQ: INMD) stands out as a company that has carved a niche in the aesthetic healthcare market. Based in Israel, InMode..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds